收费全文 | 10242篇 |
免费 | 750篇 |
国内免费 | 31篇 |
耳鼻咽喉 | 91篇 |
儿科学 | 327篇 |
妇产科学 | 247篇 |
基础医学 | 1297篇 |
口腔科学 | 737篇 |
临床医学 | 715篇 |
内科学 | 2192篇 |
皮肤病学 | 221篇 |
神经病学 | 1112篇 |
特种医学 | 201篇 |
外科学 | 1171篇 |
综合类 | 68篇 |
一般理论 | 9篇 |
预防医学 | 1056篇 |
眼科学 | 112篇 |
药学 | 716篇 |
中国医学 | 66篇 |
肿瘤学 | 685篇 |
2023年 | 133篇 |
2022年 | 261篇 |
2021年 | 457篇 |
2020年 | 317篇 |
2019年 | 428篇 |
2018年 | 449篇 |
2017年 | 321篇 |
2016年 | 315篇 |
2015年 | 376篇 |
2014年 | 480篇 |
2013年 | 585篇 |
2012年 | 817篇 |
2011年 | 808篇 |
2010年 | 457篇 |
2009年 | 415篇 |
2008年 | 630篇 |
2007年 | 598篇 |
2006年 | 502篇 |
2005年 | 485篇 |
2004年 | 406篇 |
2003年 | 359篇 |
2002年 | 352篇 |
2001年 | 162篇 |
2000年 | 124篇 |
1999年 | 110篇 |
1998年 | 70篇 |
1997年 | 32篇 |
1996年 | 32篇 |
1995年 | 22篇 |
1994年 | 28篇 |
1993年 | 15篇 |
1992年 | 56篇 |
1991年 | 44篇 |
1990年 | 49篇 |
1989年 | 30篇 |
1988年 | 27篇 |
1987年 | 31篇 |
1986年 | 22篇 |
1985年 | 18篇 |
1984年 | 16篇 |
1983年 | 17篇 |
1978年 | 11篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1974年 | 11篇 |
1972年 | 12篇 |
1969年 | 9篇 |
1968年 | 10篇 |
1967年 | 9篇 |
1966年 | 14篇 |
Background
Acute liver failure (ALF) is a clinical syndrome that results from the abrupt loss of liver function in a patient without previous liver disease. The most frequent causes are viral hepatitis, drug induced, and autoimmune disease, but in 20% of cases no cause is identified. Carthamus tinctorius (safflower) oil is used as a dietary supplement for weight loss and antioxidant. There are 4 cases described in the literature of ALF induced by the use of this substance. The objective of this study was to report 3 cases of ALF treated at the Clinical Hospital of the State University of Campinas that suggest the use of C tinctorius oil as a probable etiologic factor.Case Reports
The 3 patients had a diagnosis of ALF according to the King's College criteria. All had a history of ingestion of this oil for weight loss. During etiologic evaluation, viral hepatitis, autoimmune diseases, or any other drug cause were excluded, thus pointing to C tinctorius oil as the triggering factor. All 3 patients underwent liver transplantation: 2 had good postoperative evolution, and 1 died 12 days after the procedure.Conclusions
Two cases are described in which the hepatic insufficiency induced by C tinctorius oil was successfully treated through liver transplantation. This highlights the risk of misuse of this substance for weight loss. 相似文献Objectives
The aim of this study is to evaluate the effect of massive weight loss on the seminal parameters at 6 months from bariatric surgery.Design
Two-armed prospective study performed in 31 morbidly obese men, undergoing laparoscopic roux-en-Y-gastric bypass (n = 23) or non-operated (n = 8), assessing sex hormones, conventional (sperm motility, morphology, number, semen volume), and non-conventional (DNA fragmentation and seminal interleukin-8), semen parameters, at baseline and after 6 months from surgery or patients’ recruitment.Results
In operated patients only, a statistically significant improvement in the sex hormones was confirmed. Similarly, a positive trend in the progressive/total sperm motility and number was observed, though only the increase in semen volume and viability was statistically significant (Δ = 0.6 ml and 10%, P < 0.05, respectively). A decrease in the seminal interleukin-8 levels and in the sperm DNA fragmentation was also present after bariatric surgery, whereas these parameters even increased in non-operated subjects. Age-adjusted multivariate analysis showed that the BMI variations significantly correlated with the changes in the sperm morphology (β = ?0.675, P = 0.025), sperm number (β = 0.891, P = 0.000), and semen volume (r = 0.618, P = 0.015).Conclusion
The massive weight loss obtained with bariatric surgery was associated with an improvement in some semen parameters. The correlations found between weight loss and semen parameter variations after surgery suggest that these might occur early downstream of the testis and more slowly than the changes in the sex hormones.Objective
Lung transplantation (LT) has been proposed as a treatment for advanced interstitial lung disease (ILD) and/or pulmonary hypertension (PH) associated to systemic sclerosis (SSc) but few studies have been reported. The aim of this study was to describe the clinical features, complications and survival of a single-center cohort of patients with SSc that underwent LT and to compare their survival with a group of non-SSc transplanted patients.Methods
Fifteen patients with SSc were transplanted between May 2005 and April 2015. Standard international criteria were used to determine eligibility for LT. The severity of gastroesophageal involvement was not considered as a major contraindication if symptoms were under control.Results
Eight (53.3%) patients had diffuse cutaneous SSc. Eleven (73%) underwent bilateral LT. The main indication for LT was ILD, with or associated PH in 4 cases. Acute cellular rejection and infections were the most frequent complications. Functional lung tests tended to keep stable after transplantation. Median survival was 2.4 years (Q1–Q3: 0.7–3.7 years). We did not find differences in survival between patients transplanted with SSc versus those transplanted due to non-SSc ILD or PH. SSc complications were scarce with no patient developing PH after LT.Conclusions
LT was an effective treatment for advanced ILD and/or PH associated to SSc in our study. Gastroesophageal reflux was not a limitation for LT in SSc in this study. Complications and survival did not differ from non-SSc patients undergoing LT. 相似文献Inflammation is widely recognized as the driving force of cachexia induced by chronic diseases; however, therapies targeting inflammation do not always reverse cachexia. Thus, whether inflammation per se plays an important role in the clinical course of cachectic patients is still a matter of debate.
AimsTo give new insights into cachexia’s pathogenesis and diagnosis, we performed a comprehensive literature search on the contribution of inflammatory markers to this syndrome, focusing on the noncommunicable diseases cancer and cardiovascular diseases.
MethodsA systematic review was performed in PubMed using the keywords (“cancer” OR “cardiac” cachexia AND “human” OR “patient” AND “plasma” or “serum”). A total of 744 studies were retrieved and, from these, 206 were selected for full-text screening. In the end, 98 papers focusing on circulating biomarkers of cachexia were identified, which resulted in a list of 113 different mediators.
ResultsData collected from the literature highlight the contribution of interleukin-6 (IL-6) and C-reactive protein (CRP) to cachexia, independently of the underlying condition. Despite not being specific, once the diagnosis of cachexia is established, CRP might help to monitor the effectiveness of anti-cachexia therapies. In cardiac diseases, B-type natriuretic peptide (BNP), renin, and obestatin might be putative markers of body wasting, whereas in cancer, growth differentiation factor (GDF) 15, transforming growth factor (TGF)-β1 and vascular endothelial growth factor (VEGF) C seem to be better markers of this syndrome. Independently of the circulating mediators, NF-κB and JAK/STAT signaling pathways play a key role in bridging inflammation with muscle wasting; however, therapies targeting these pathways were not proven effective for all cachectic patients.
ConclusionThe critical and integrative analysis performed herein will certainly feed future research focused on the better comprehension of cachexia pathogenesis toward the improvement of its diagnosis and the development of personalized therapies targeting specific cachexia phenotypes.
相似文献